Jul 28, 2026 07:01AM
Jul 28, 2026 07:00AM
Jul 16, 2026 07:32AM
Jul 16, 2026 07:30AM
Jun 22, 2026 07:02AM
Jun 22, 2026 07:00AM
Jun 8, 2026 08:11AM Galmed to acquire Colospan for $4.5 million in medical device deal
Jun 8, 2026 08:10AM
Jun 2, 2026 07:31AM
Jun 2, 2026 07:30AM
May 14, 2026 07:31AM
May 14, 2026 07:30AM
May 6, 2026 07:32AM
May 6, 2026 07:30AM Tissue Dynamics and Galmed Pharmaceuticals to Develop Human-Centered Chronic Cardiac Fibrosis Platform to Advance Aramchol-Based Therapeutics
Apr 14, 2026 07:32AM
Apr 14, 2026 07:30AM
Apr 9, 2026 07:30AM
Mar 31, 2026 04:15PM
Jan 30, 2026 04:15PM
Jan 30, 2026 04:15PM
Dec 8, 2025 08:32AM Galmed to present cancer research at HEP-DART 2025 conference
Dec 8, 2025 08:30AM
Dec 4, 2025 08:32AM
Dec 4, 2025 08:30AM
Dec 1, 2025 08:30AM
Dec 1, 2025 08:30AM
Nov 26, 2025 08:30AM
Nov 18, 2025 08:30AM Galmed Announces Meaningful Top Line Results from AM-001 Study of Aramchol Meglumine
Nov 17, 2025 08:31AM
Nov 17, 2025 08:30AM
Aug 28, 2025 08:00AM
Aug 25, 2025 07:31AM
Aug 25, 2025 07:30AM
May 27, 2025 08:00AM
May 22, 2025 08:00AM Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025 08:00AM
May 6, 2025 07:30AM
Apr 28, 2025 08:00AM
Apr 17, 2025 08:30AM
Apr 15, 2025 08:32AM
Apr 15, 2025 08:30AM
Apr 10, 2025 08:00AM Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor
Apr 2, 2025 04:10PM
Sep 25, 2024 08:01AM
Sep 25, 2024 08:00AM
Sep 20, 2024 09:00AM
Sep 19, 2024 07:06AM
Sep 19, 2024 07:00AM
Apr 4, 2024 05:06PM Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2023
Mar 15, 2024 09:01AM

328,164 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All